Cargando…
A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
The history of biomarkers and ultrasonography dates back over more than 50 years. The present status of biomarkers used in the context of ovarian cancer is addressed. Attention is given to new interpretations of the etiology of ovarian cancer. Cancer antigen 125 (CA125) and multivariate index assays...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373023/ https://www.ncbi.nlm.nih.gov/pubmed/28282875 http://dx.doi.org/10.3390/diagnostics7010014 |